Clinical Trial Update: Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intra-arterial hepatic bevacizumab in combination with systemic chemotherapy for colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED